The US FDA New Drug Approvals in October 2024

Shots: PharmaShots has compiled a list of US FDA-approved drugs in the month of October 2024 The US FDA has approved a total of 4 new drugs including 2 new molecular entities and 2 biologics leading to the treatment of patients and advances in the healthcare industry The major highlighted drugs were Pfizer’s Hympavzi for…

ByDipanshu DixitNovember 12, 2024

INSIGHTS+

EMA Marketing Authorization of New Drugs in September 2024

Shots: The EMA’s CHMP has granted positive opinion to 4 Biologics and 1 New Chemical Entity in September 2024, leading to treatments for patients and advances in the healthcare industry The major highlighted drugs were AbbVie’s Elahere to treat Ovarian Cancer and Pfizer’s Hympavzi for Hemophilia A and B PharmaShots has compiled a list of 3 drugs that have been…

ByDipanshu DixitOctober 24, 2024

INSIGHTS+

The US FDA New Drug Approvals in September 2024

Shots: PharmaShots has compiled a list of US FDA-approved drugs in the month of September 2024 The US FDA has approved a total of 7 new drugs including 4 new molecular entities and 3 biologics leading to the treatment of patients and advances in the healthcare industry The major highlighted drugs were Roche’s Tecentriq Hybreza & Ocrevus Zunovo for…

ByDipanshu DixitOctober 22, 2024

THOUGHTSPOT

Mastering a Changing Landscape: How to Stay Current with Healthcare Industry Changes

The healthcare industry is constantly changing, with new technologies, regulations, policies, and best practices emerging daily. Therefore, healthcare professionals need to stay up to date and informed to provide quality care, improve their skills, and advance their careers. Staying current with industry changes — and mastering a constantly changing healthcare landscape — is paramount across…

ByFatima BatoolOctober 18, 2024

THOUGHTSPOT

How Rising Drug Prices Affect Your Insurance

The cost of prescription drugs has been increasing over the past years across the United States. Its impact steadily affects all healthcare industry sectors, especially health insurance policies. Employers are finding it difficult to get the value of what they insure, therefore passing the cost of drugs to employees. In a recent study by AHIP, over…

ByEvans JamesSeptember 26, 2024

INSIGHTS+

Insights+: EMA Marketing Authorization of New Drugs in August 2024

Shots: The EC has approved to 5 Biologics and 3 New Chemical Entities in August 2024, leading to treatments for patients and advances in the healthcare industry The major highlighted drugs were Johnson & Johnson’s Balversa to treat Metastatic Urothelial Carcinoma (mUC) and Takeda’s Adzynma for Congenital Thrombotic Thrombocytopenic Purpura (cTTP) PharmaShots has compiled a list…

ByDipanshu DixitSeptember 24, 2024

INSIGHTS+

Insights+: EMA Marketing Authorization of New Drugs in July 2024

Shots: The EMA granted Positive Opinion to 2 Biologics and 5 New Chemical Entities in July 2024, leading to treatments for patients and advances in the healthcare industry The major highlighted drugs were Johnson & Johnson’s Yuvanci to treat Pulmonary Arterial Hypertension (PAH) and Astellas’ Vyloy + CT for Gastric & Gastroesophageal Junction Cancer PharmaShots has compiled a list…

ByDipanshu DixitAugust 14, 2024

INSIGHTS+

Insights+: The US FDA New Drug Approvals in July 2024

Shots: PharmaShots has compiled a list of US FDA-approved drugs in the month of July 2024 The US FDA approved a total of 2 new drugs including 1 new molecular entity and 1 biologic leading to the treatments for patients and advances in the healthcare industry The major highlighted drug was Eli Lilly’s Kisunla for…

ByDipanshu DixitAugust 13, 2024

INSIGHTS+

Insights+: EMA Marketing Authorization of New Drugs in June 2024

Shots: The EMA granted Positive Opinion to 4 Biologics and 3 New Chemical Entities in June 2024, leading to treatments for patients and advances in the healthcare industry The major highlighted drugs were Merck’s Winrevair to treat Pulmonary Arterial Hypertension (PAH) and Roche’s PiaSky for Paroxysmal Nocturnal Haemoglobinuria (PNH) PharmaShots has compiled a list of 5 drugs that…

ByDipanshu DixitJuly 23, 2024

INSIGHTS+

Disease of the Month – Small Cell Lung Cancer

Shots: Small cell lung cancer (SCLC) aka Oat cell carcinoma is a rare & fast-growing lung cancer and ~15% of bronchogenic carcinomas are SCLC In this reprise of our Disease of the Month report, we bring an illuminating account of SCLC with a dive analysis of epidemiology, market size, disease management, available therapies, patient advocacy…

ByDipanshu DixitJuly 18, 2024

The US FDA New Drug Approvals in October 2024

EMA Marketing Authorization of New Drugs in September 2024

The US FDA New Drug Approvals in September 2024

Mastering a Changing Landscape: How to Stay Current with Healthcare Industry Changes

How Rising Drug Prices Affect Your Insurance

Insights+: EMA Marketing Authorization of New Drugs in August 2024

Insights+: EMA Marketing Authorization of New Drugs in July 2024

Insights+: The US FDA New Drug Approvals in July 2024

Insights+: EMA Marketing Authorization of New Drugs in June 2024

Disease of the Month – Small Cell Lung Cancer

Contact US

OUR INFORMATION

FOLLW US

FOLLW US

Sign Up to Our Newsletter